ESSA Pharma
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.86-1.40-0.96-1.11
Price/Sales ratio
N/A18.85N/A2.79
Earnings per Share (EPS)
$-1.02$-1.36$-1.98$-1.71

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-13.51-5.63-1.87-1.23-2.72-6.60-8.36-2.28-5.12N/A-3.92-6.60
Price/Sales ratio
N/A340.94KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
26.14-137.77-1.971.570.571.951.580.470.932.090.790.57
Price/Cash Flow ratio
-9.41-4.83-0.48-1.40-2.32-9.11-12.11-2.79-6.88-11.81-4.61-9.11
Price/Free Cash Flow ratio
-9.29-4.83-0.48-1.40-2.32-9.11-12.11-2.79-6.88-11.81-4.61-9.11
Price/Earnings Growth ratio
-0.04-1.220.020.070.050.401.080.130.20N/A-0.230.40
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A-30398.15%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/A-9051612.90%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/A-5985714.28%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/A-6055299.53%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-0.90%-1.16%-2.64%-0.23%-0.36%1.21%0.09%0.31%-0.00%N/A0.34%-0.36%
Return on Assets
-114.32%-126.32%-80.23%-72.61%-19.06%-29.09%-18.57%-20.70%-17.82%N/A-19.84%-19.84%
Return On Equity
-193.45%2446.92%105.26%-127.07%-21.22%-29.58%-18.97%-21.00%-18.25%N/A-19.28%-21.22%
Return on Capital Employed
-210.25%-290.04%-636.72%-85.23%-24.70%-29.12%-19.00%-21.13%-22.06%N/A-22.05%-24.70%
Liquidity Ratios
Current Ratio
2.290.911.264.669.7466.72N/AN/AN/AN/A56.079.74
Quick Ratio
2.292.861.494.669.8867.1750.2825.4942.5738.6455.569.88
Cash ratio
0.512.471.044.439.5646.7735.0724.709.6431.4117.459.56
Days of Sales Outstanding
N/A26.71KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A-87.59-233.144.45KN/A-1.02KN/A331.49KN/AN/AN/A-1.02K
Operating Cycle
N/A26.62KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A19.51K10.38K5.54KN/A2.24K4.75K2.86K6.24KN/AN/A2.24K
Cash Conversion Cycle
N/A7.10KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A1.410.390.06N/AN/AN/AN/AN/A0.01N/A
Debt Equity Ratio
N/AN/A-1.860.690.07N/AN/AN/AN/AN/A0.01N/A
Long-term Debt to Capitalization
N/AN/A3.570.27N/AN/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
N/AN/A2.150.400.07N/AN/AN/AN/AN/A0.00N/A
Interest Coverage Ratio
-118.73-19.94-13.85-11.84-20.19-38.05N/AN/AN/AN/A-3.03K-38.05
Cash Flow to Debt Ratio
N/AN/A-2.18-1.61-3.30N/AN/AN/AN/AN/A-156.65N/A
Company Equity Multiplier
1.69-19.37-1.311.751.111.011.021.011.0211.011.01
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-70.51KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.011.001111111111
Cash Flow Coverage Ratio
N/AN/A-2.18-1.61-3.30N/AN/AN/AN/AN/A-156.65N/A
Short Term Coverage Ratio
N/AN/A-8.56-3.62-3.30N/AN/AN/AN/AN/A-214.97N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A